Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F9NwPB80EwkaEhHoREDhh1rqgkek.uncropped.jpg&w=3840&q=75)
Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check10 days agoChange DetectedThe website has added new content, while the FDA Safety Alerts and Recalls section has been removed.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check31 days agoChange DetectedThe website has added extensive contact information for various study sites across multiple locations, including new contacts and details for sites in California, Canada, Bulgaria, Germany, Mexico, Spain, and the UK, while removing previous enrollment details and study counts.SummaryDifference46%
- Check45 days agoChange DetectedThe study has expanded to include 198 locations, and the website has been updated to version 2.10.0, replacing the previous version 2.9.7.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.